1311.2.46001 Boehringer Ingelheim Investigational Site
Stockholm
0 studies enrolling now ยท 1 studies all time
What they study most
Psoriasis
Studies at this site
BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab
โ Completed